Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| I226R Protein of African Swine Fever Virus Is a Suppressor of Innate Antiviral Responses. | Viruses | 2022 | 35336982 | PubTator, text mining | PubMed |
| Conserved Targets to Prevent Emerging Coronaviruses. | Viruses | 2022 | 35336969 | PubTator, text mining | PubMed |
| Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin. | Viruses | 2022 | 35336937 | PubTator, text mining | PubMed |
| Whole Genome Sequence Analysis of a Prototype Strain of the Novel Putative Rotavirus Species L. | Viruses | 2022 | 35336869 | PubTator, text mining | PubMed |
| Innate Immune Response in SARS-CoV-2 Infection. | Microorganisms | 2022 | 35336077 | PubTator, text mining | PubMed |
| In silico study of potential antiviral activity of copper(II) complexes with non-steroidal anti-inflammatory drugs on various SARS-CoV-2 target proteins. | J Inorg Biochem | 2022 | 35334392 | PubTator, text mining | PubMed |
| The Role of Oral Antivirals for COVID-19 Treatment in Shaping the Pandemic Landscape. | J Pers Med | 2022 | 35330439 | PubTator, text mining | PubMed |
| Artificial Intelligence Technologies for COVID-19 De Novo Drug Design. | Int J Mol Sci | 2022 | 35328682 | PubTator, text mining | PubMed |
| Coronavirus Genomes and Unique Mutations in Structural and Non-Structural Proteins in Pakistani SARS-CoV-2 Delta Variants during the Fourth Wave of the Pandemic. | Genes (Basel) | 2022 | 35328105 | PubTator, text mining | PubMed |
| An extended conformation of SARS-CoV-2 main protease reveals allosteric targets. | Proc Natl Acad Sci U S A | 2022 | 35324337 | PubTator, text mining | PubMed |
| High-Content Screening and Computational Prediction Reveal Viral Genes That Suppress the Innate Immune Response. | mSystems | 2022 | 35319251 | PubTator, text mining | PubMed |
| Orally administered bismuth drug together with N-acetyl cysteine as a broad-spectrum anti-coronavirus cocktail therapy. | Chem Sci | 2022 | 35310492 | PubTator, text mining | PubMed |
| Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review. | J Mol Liq | 2022 | 35309259 | PubTator, text mining | PubMed |
| Discovery of 4'-O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor. | Biochem Biophys Res Commun | 2022 | 35303682 | PubTator, text mining | PubMed |
| When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2. | J Virol | 2022 | 35293770 | PubTator, text mining | PubMed |
| The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition. | Cell Res | 2022 | 35292745 | PubTator, text mining | PubMed |
| Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review. | Front Pharmacol | 2022 | 35281901 | PubTator, text mining | PubMed |
| Potential Inhibitors Targeting Papain-Like Protease of SARS-CoV-2: Two Birds With One Stone. | Front Chem | 2022 | 35281561 | PubTator, text mining | PubMed |
| Role of Histone Post-Translational Modifications in Inflammatory Diseases. | Front Immunol | 2022 | 35280995 | PubTator, text mining | PubMed |
| A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors. | Antiviral Res | 2022 | 35278581 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=57